Duck Creek Applied sciences (NASDAQ:DCT – Get Rating) up to date its FY23 earnings steering on Thursday. The corporate supplied EPS steering of $0.13-0.14 for the interval, in comparison with the consensus EPS estimate of $0.12. The corporate issued income steering of $331-338 million, in comparison with the consensus income estimate of $330.37 million. Duck Creek Applied sciences additionally up to date its FY 2023 steering to $0.13-$0.14 EPS.
Wall Avenue Analysts Forecast Development
A number of analysis corporations lately commented on DCT. StockNews.com started protection on shares of Duck Creek Applied sciences in a analysis be aware on Wednesday, October twelfth. They issued a maintain score on the inventory. Barclays lower their worth goal on shares of Duck Creek Applied sciences from $21.00 to $14.00 and set an obese score for the corporate in a analysis report on Wednesday, October twelfth. Royal Financial institution of Canada lower their worth goal on shares of Duck Creek Applied sciences from $14.00 to $12.00 and set a sector carry out score for the corporate in a analysis report on Thursday, October thirteenth. Needham & Firm LLC lower their worth goal on shares of Duck Creek Applied sciences from $20.00 to $16.00 and set a purchase score for the corporate in a analysis report on Thursday, October thirteenth. Lastly, DA Davidson lower their worth goal on shares of Duck Creek Applied sciences from $30.00 to $27.00 in a analysis report on Thursday, October thirteenth. One analysis analyst has rated the inventory with a promote score, 5 have given a maintain score and three have given a purchase score to the inventory. In line with MarketBeat.com, the corporate presently has a consensus score of Maintain and a mean worth goal of $17.11.
Duck Creek Applied sciences Inventory Down 2.3 %
Shares of DCT stock traded down $0.27 on Thursday, reaching $11.28. The corporate had a buying and selling quantity of 958,556 shares, in comparison with its common quantity of 984,787. The inventory has a market capitalization of $1.50 billion, a PE ratio of -187.97, a price-to-earnings-growth ratio of 6.69 and a beta of 0.22. Duck Creek Applied sciences has a one yr low of $10.04 and a one yr excessive of $32.49. The enterprise’s 50-day shifting common is $11.38 and its 200 day shifting common is $12.12.
Duck Creek Applied sciences (NASDAQ:DCT – Get Rating) final posted its earnings outcomes on Wednesday, October twelfth. The corporate reported $0.01 EPS for the quarter. The agency had income of $80.70 million in the course of the quarter, in comparison with analysts’ expectations of $73.08 million. Duck Creek Applied sciences had a damaging web margin of two.75% and a optimistic return on fairness of 1.03%. The enterprise’s income for the quarter was up 13.8% in comparison with the identical quarter final yr. Throughout the identical quarter within the prior yr, the enterprise earned $0.02 earnings per share. On common, sell-side analysts forecast that Duck Creek Applied sciences will publish 0.06 earnings per share for the present fiscal yr.
Institutional Inflows and Outflows
Institutional buyers and hedge funds have lately made adjustments to their positions within the firm. UBS Group AG elevated its stake in shares of Duck Creek Applied sciences by 115.9% within the first quarter. UBS Group AG now owns 19,549 shares of the corporate’s inventory valued at $432,000 after shopping for a further 10,495 shares in the course of the interval. Advisory Companies Community LLC acquired a brand new place in shares of Duck Creek Applied sciences within the first quarter valued at roughly $306,000. Hsbc Holdings PLC acquired a brand new place in shares of Duck Creek Applied sciences within the first quarter valued at roughly $286,000. HighTower Advisors LLC elevated its stake in shares of Duck Creek Applied sciences by 36.2% within the first quarter. HighTower Advisors LLC now owns 12,728 shares of the corporate’s inventory valued at $282,000 after shopping for a further 3,383 shares in the course of the interval. Lastly, Quantbot Applied sciences LP elevated its stake in shares of Duck Creek Applied sciences by 309.4% within the first quarter. Quantbot Applied sciences LP now owns 10,989 shares of the corporate’s inventory valued at $243,000 after shopping for a further 8,305 shares in the course of the interval. Institutional buyers and hedge funds personal 74.55% of the corporate’s inventory.
About Duck Creek Applied sciences
Duck Creek Applied sciences, Inc offers software-as-a-service core programs to the property and casualty insurance coverage trade in the USA and internationally. The corporate offers Duck Creek Coverage, an answer that permits insurers to develop and launch new insurance coverage merchandise and handle varied facets of coverage administration starting from product definition to quoting, binding, and servicing; Duck Creek Billing that gives fee and invoicing capabilities, akin to billing and collections, fee processing, disbursement administration, and common ledger capabilities for insurance coverage strains and invoice varieties; and Duck Creek Claims that helps total claims lifecycle from first discover of loss by way of investigation, funds, negotiations, reporting, and closure.
Featured Articles
This on the spot information alert was generated by narrative science know-how and monetary knowledge from MarketBeat to be able to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial group previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you contemplate Duck Creek Applied sciences, you will wish to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they advocate to their purchasers each day. MarketBeat has recognized the five stocks that high analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Duck Creek Applied sciences wasn’t on the record.
Whereas Duck Creek Applied sciences at present has a “Maintain” score amongst analysts, top-rated analysts consider these 5 shares are higher buys.
